Ethics approval received for RC220 Phase 1 Trial
Released 13 Mar 25
Latest announcements
Announcement summary
Ethics approval received for RC220 Phase 1 Trial
Ask a question
Your question will be sent privately to Race Oncology. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Race Oncology a question about this announcement.